Pooled Analysis of Five-Year Data from Two Phase 3 Studies Further Supports Overall Survival Advantage Observed in Patients with Myelofibrosis Treated With Jakafi® (ruxolitinib)
New Zealand Business Confidence Eases in November
Australian Full Time Employment Rises in Oct
Australia Wage Growth Falls to Record Low
Water-Based Personal Lubricant – Market Trends and Forecasts From Technavio
Big-Name Brands Go to War Over Department Store Sales -- WSJ
LIVESTOCK HIGHLIGHTS: Top Stories of the Day
The U.S. economy is in decent shape, but we are being even more selective given recent outperformance.
As macro headwinds mount, we would look for a larger valuation discount among consumer cyclical names.